Literature DB >> 10630726

Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada.

J A Johnson1, A S Pickard.   

Abstract

OBJECTIVES: The purposes of this analysis were to evaluate the construct validity of the EQ-5D and compare responses on the EQ-5D with the Physical Component Summary (PCS-12) and Mental Component Summary (MCS-12) scores of the SF-12 Health Survey.
METHODS: Data were collected via a survey instrument mailed to 4,200 randomly selected subjects in the province of Alberta, Canada. The instrument contained the EQ-5D and SF-12 health surveys, with additional questions eliciting clinical and demographic information from the respondents.
RESULTS: 1,555 respondents returned mailed questionnaires; 606 questionnaires were returned undeliverable. The SF-12 summary scores were calculated for 1,380 respondents. Analysis of the EQ-5D responses by demographic variables found significant differences among categories of age, gender, and self-reported chronic medical conditions. Corresponding dimensions and summary scores were more strongly related (eg, mobility and PCS-12; F ratio = 598.3, P < 0.001) than dissimilar dimensions (eg, mobility and MCS-12; F ratio = 18.8, P < 0.001). The EQ-5D index scores were moderately correlated with SF-12 summary scores (r = 0.41 for MCS-12 and r = 0.68 for PCS-12). For subjects reporting no problems on the EQ-5D, PCS-12 and MCS-12 scores were significantly lower for people reporting medical problems or feelings of depression.
CONCLUSIONS: The results of this investigation generally supported the validity of the EQ-5D. However, an important ceiling effect was observed for the EQ-5D in this sample. The combination of the EQ-5D and SF-12 provides relatively broad coverage of important health domains and scores for various purposes.

Entities:  

Mesh:

Year:  2000        PMID: 10630726     DOI: 10.1097/00005650-200001000-00013

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  101 in total

1.  Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication.

Authors:  J L Bosch; M G Hunink
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

2.  Swedish population health-related quality of life results using the EQ-5D.

Authors:  K Burström; M Johannesson; F Diderichsen
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

3.  The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study.

Authors:  Mélanie Drolet; Marc Brisson; Kenneth E Schmader; Myron J Levin; Robert Johnson; Michael N Oxman; David Patrick; Caty Blanchette; James A Mansi
Journal:  CMAJ       Date:  2010-10-04       Impact factor: 8.262

4.  Understanding differences between self-ratings and population ratings for health in the EuroQOL.

Authors:  Ralph P Insinga; Dennis G Fryback
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

5.  Understanding health state valuations: a qualitative analysis of respondents' comments.

Authors:  Nancy J Devlin; Paul Hansen; Caroline Selai
Journal:  Qual Life Res       Date:  2004-09       Impact factor: 4.147

6.  Discriminative capacity of the EQ-5D, SF-6D, and SF-12 as measures of health status in population health survey.

Authors:  Oriol Cunillera; Ricard Tresserras; Luis Rajmil; Gemma Vilagut; Pilar Brugulat; Mike Herdman; Anna Mompart; Antonia Medina; Yolanda Pardo; Jordi Alonso; John Brazier; Montse Ferrer
Journal:  Qual Life Res       Date:  2010-03-31       Impact factor: 4.147

7.  Construct validity of the SF-12 among American Indian and Alaska Native people using two known scoring methods.

Authors:  Sandra L Edwards; Molly McFadden; Anne P Lanier; Maureen A Murtaugh; Elizabeth D Ferucci; Diana G Redwood; Lillian Tom-Orme; Martha L Slattery
Journal:  J Health Care Poor Underserved       Date:  2012-08

8.  No detectable association between frequency of marijuana use and health or healthcare utilization among primary care patients who screen positive for drug use.

Authors:  Daniel Fuster; Debbie M Cheng; Donald Allensworth-Davies; Tibor P Palfai; Jeffrey H Samet; Richard Saitz
Journal:  J Gen Intern Med       Date:  2013-09-19       Impact factor: 5.128

9.  The EQ-5D-5L Improves on the EQ-5D-3L for Health-related Quality-of-life Assessment in Patients Undergoing Total Hip Arthroplasty.

Authors:  Meridith E Greene; Kevin A Rader; Göran Garellick; Henrik Malchau; Andrew A Freiberg; Ola Rolfson
Journal:  Clin Orthop Relat Res       Date:  2015-11       Impact factor: 4.176

10.  Psychometric properties of the EQ-5D-5L in the general population of South Korea.

Authors:  Tae Hyup Kim; Min-Woo Jo; Sang-il Lee; Seon Ha Kim; Son Mi Chung
Journal:  Qual Life Res       Date:  2012-12-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.